The Indian maker of a cough syrup that was linked to the death of 19 children in Uzbekistan said on December 30 that it had halted production of all medicines after an inspection by the drug regulator. Indian media reported that the inspectors had found deviations from the rules on manufacturing at one of Marion Biotech's units. India's drug regulator and regional authorities had inspected Marion Biotech's facility in Noida, close to Delhi, India's Health Ministry said. To read the original story from Reuters, click here.
Indian Maker Of Cough Syrup Linked To Uzbekistan Deaths Halts Production
Police are seen at the gate of an office of Marion Biotech, a health-care and pharmaceutical company, in Noida, India, on December 29.